Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€170.05

€170.05

1.820%
3.05
1.820%
€261.08
 
05.06.26 / Tradegate WKN: 895878 / Symbol: RMD / Name: ResMed / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Resmed Inc. Stock

Resmed Inc. gained 1.820% today.
Resmed Inc. is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
As a result the target price of 261 € shows a very positive potential of 53.48% compared to the current price of 170.05 € for Resmed Inc..

Pros and Cons of Resmed Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Resmed Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Resmed Inc. 1.820% 4.038% -4.332% -22.138% -18.441% -18.009% 0.741%
Veeva Systems A -2.570% 0.234% 2.322% -40.907% -21.775% -17.054% -36.793%
Thermo Fisher Scientific Inc. -1.420% -2.865% 2.781% 17.789% -16.997% -15.248% 11.195%
Boston Scientific 0.130% 1.690% -11.963% -53.189% -48.243% -12.211% 21.975%

Comments

ResMed (RMD) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -13.17%
Target price 218.178
Change
Ends at 13.04.27

ResMed (RMD) was given a new $255.00 price target by Evercore Inc. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -12.77%
Target price 291.550
Change
Ends at 09.04.27

ResMed (RMD) had its price target lowered by Citigroup Inc. from $345.00 to $340.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
Show more